Experiment 1164986
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | WALTHER,PJ: WILLIAMS,SD: TRONER,M: GRECO,FA: BIRCH,R: EINHORN,LH:. (1986). PHASE II STUDY OF ETOPOSIDE FOR CARCINOMA OF THE PROSTATE.. 70(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II CLINICAL TRIAL, ETOPOSIDE WAS EVALUATED FOR SINGLE AGENT USE IN CARCINOMA OF THE PROSTATE. THE DRUG WAS INFUSED OVER 30 MINUTES DAILY FOR 3 DAYS AND REPEATED ON DAY 21. OF 38 PATIENTS EVALUABLE FOR RESPONSE, THERE WAS ONE PARTIAL RESPONSE AND 4 STABLE DISEASE. TOXICITY WAS MODERATE, THOUGH ONE PATIENT DEVELOPED LIFE THREATENING LEUKOPENIA. |
| Dose amount | 130.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |